Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1990;81:914-921

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brodde, O. E.
Right arrow Articles by Michel, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brodde, O. E.
Right arrow Articles by Michel, M. C.

Circulation, Vol 81, 914-921, Copyright © 1990 by American Heart Association


ARTICLES

Agonist-induced desensitization of beta-adrenoceptor function in humans. Subtype-selective reduction in beta 1- or beta 2-adrenoceptor- mediated physiological effects by xamoterol or procaterol

OE Brodde, A Daul, M Michel-Reher, F Boomsma, AJ Man in 't Veld, P Schlieper and MC Michel
Biochemical Research Lab, University of Essen, FRG.

We investigated the effects of beta 2- (procaterol 2 x 50 micrograms/day for 9 days) and beta 1- (xamoterol 2 x 200 mg/day for 14 days) adrenoceptor agonists on lymphocyte beta 2-adrenoceptor density and beta 1- and beta 2-adrenoceptor in vivo function (assessed as isoprenaline-infusion-evoked hemodynamic effects and exercise-induced tachycardia) in healthy volunteers. Procaterol decreased lymphocyte beta 2-adrenoceptor density and all beta 2-adrenoceptor-mediated in vivo effects but did not affect beta 1-adrenoceptor-mediated in vivo effects. In contrast, xamoterol neither affected lymphocyte beta 2- adrenoceptors nor beta 2-adrenoceptor-mediated in vivo effects but decreased beta 1-adrenoceptor-mediated in vivo effects. It is concluded that in humans, generally long-term application of beta 1- or beta 2- adrenoceptor agonists causes desensitization of beta-adrenoceptor function but in a beta-adrenoceptor subtype-selective fashion.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
F. Marion-Latard, I. De Glisezinski, F. Crampes, M. Berlan, J. Galitzky, H. Suljkovicova, D. Riviere, and V. Stich
A single bout of exercise induces {beta}-adrenergic desensitization in human adipose tissue
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R166 - R173.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. M. Feldman and C. McTiernan
New Insight Into the Role of Enhanced Adrenergic Receptor-Effector Coupling in the Heart
Circulation, August 10, 1999; 100(6): 579 - 582.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
K. Schaller, D. Mechau, H. G. Scharmann, M. Weiss, M. Baum, and H. Liesen
Increased training load and the beta -adrenergic-receptor system on human lymphocytes
J Appl Physiol, July 1, 1999; 87(1): 317 - 324.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
U. Poller, B. Fuchs, A. Gorf, J. Jakubetz, J. Radke, K. Ponicke, and O.-E. Brodde
Terbutaline-induced desensitization of human cardiac {beta}2-adrenoceptor-mediated positive inotropic effects: attenuation by ketotifen
Cardiovasc Res, October 1, 1998; 40(1): 211 - 222.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. M. Stein, R. Nelson, R. Deegan, H. He, T. Inagami, M. Frazer, K. F. Badr, M. Wood, and A. J. J. Wood
Tachyphylaxis of Human Forearm Vascular Responses Does Not Occur Rapidly After Exposure to Isoproterenol
Hypertension, June 1, 1995; 25(6): 1294 - 1300.
[Abstract] [Full Text]